Correlation Between Oncolytics Biotech and DiaMedica Therapeutics

Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncolytics Biotech and DiaMedica Therapeutics, you can compare the effects of market volatilities on Oncolytics Biotech and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and DiaMedica Therapeutics.

Diversification Opportunities for Oncolytics Biotech and DiaMedica Therapeutics

-0.72

Correlation Coefficient

Oncolytics Biotech  DiaMedica Therapeutics

Pay attention - limited upside

The 3 months correlation between Oncolytics and DiaMedica is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and DiaMedica Therapeutics go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and DiaMedica Therapeutics

Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the DiaMedica Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.23 times less risky than DiaMedica Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The DiaMedica Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  566.00  in DiaMedica Therapeutics on November 28, 2024 and sell it today you would earn a total of  32.00  from holding DiaMedica Therapeutics or generate 5.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Oncolytics Biotech  vs.  DiaMedica Therapeutics

Oncolytics Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

DiaMedica Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oncolytics Biotech and DiaMedica Therapeutics

The main advantage of trading using opposite Oncolytics Biotech and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.

The idea behind Oncolytics Biotech and DiaMedica Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.